Nasdaq
IMRN
Immuron Limited
- Health Care
- Australia
- Listed 2017
- 1 day
- +0.0%
- 1 month
- −12.0%
- 1 year
- −32.9%
$1.10 · Mkt cap $8.88M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Immuron Limited
$1.10 · Mkt cap $8.88M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Immuron Limited trades under the ticker IMRN on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2017. Its market capitalisation is $8.88M. The last closing price was $1.10, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −32.9%, and −12.0% over the past month. Returns are price returns and exclude dividends.
This page exists because IMRN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.